{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:37:14Z","timestamp":1791463034984,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12020-020-02276-7","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T19:02:52Z","timestamp":1585681372000},"page":"679-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["The calcium-to-phosphorous (Ca\/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2881-982X","authenticated-orcid":false,"given":"Bruno","family":"Madeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-5683","authenticated-orcid":false,"given":"Sara","family":"De Vincentis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Repaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0026-137X","authenticated-orcid":false,"given":"Valentina","family":"Vicennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1892-9785","authenticated-orcid":false,"given":"Fabio","family":"Vescini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Amadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Balestrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4182-3110","authenticated-orcid":false,"given":"Uberto","family":"Pagotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2133-4304","authenticated-orcid":false,"given":"Manuela","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8169-0696","authenticated-orcid":false,"given":"Vincenzo","family":"Rochira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"2276_CR1","unstructured":"J.L. Shaker, L. Deftos. Calcium and Phosphate Homeostasis. [Updated 2018 Jan 19]. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000"},{"key":"2276_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"M.D. Walker, S.J. Silverberg, Primary hyperparathyroidism. Nat. Rev. Endocrinol. 14, 115\u2013125 (2018)","journal-title":"Nat. Rev. Endocrinol."},{"key":"2276_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","volume":"32","author":"S Minisola","year":"2018","unstructured":"S. Minisola, L. Gianotti, S. Bhadada, S.J. Silverberg, Classical complications of primary hyperparathyroidism. Best Pract. Res. Clin. Endocrinol. Metab. 32, 791\u2013803 (2018)","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"2276_CR4","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.2215\/CJN.05910809","volume":"5","author":"M Peacock","year":"2010","unstructured":"M. Peacock, Calcium metabolism in health and disease. Clin. J. Am. Soc. Nephrol. 5(Suppl 1), S23\u2013S30 (2010)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2276_CR5","unstructured":"B. Madeo, S. De Vincentis, E. Kara, F. Vescini, T. Trenti, et al. Reliability of calcium-phosphorus (Ca\/P) ratio as a new, accurate and inexpensive tool inthe diagnosis of some Ca-P disorders. J. Endocrinol. Investig. 42, 1041\u20131049 (2019)"},{"key":"2276_CR6","doi-asserted-by":"publisher","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","volume":"3","author":"M Mannstadt","year":"2017","unstructured":"M. Mannstadt, J.P. Bilezikian, R.V. Thakker, F.M. Hannan, B.L. Clarke et al. Hypoparathyroidism. Nat. Rev. Dis. Prim. 3, 17055 (2017)","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2276_CR7","first-page":"109","volume":"2","author":"B Madeo","year":"2018","unstructured":"B. Madeo, E. Kara, K. Cioni, S. Vezzani, T. Trenti et al. Serum calcium to phosphorous (Ca\/P) ratio is a simple, inexpensive, and accurate tool in the diagnosis of primary hyperparathyroidism. JBMR 2, 109\u2013117 (2018)","journal-title":"JBMR"},{"key":"2276_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","volume":"391","author":"JP Bilezikian","year":"2018","unstructured":"J.P. Bilezikian, L. Bandeira, A. Khan, N.E. Cusano, Hyperparathyroidism. Lancet 391, 168\u2013178 (2018)","journal-title":"Lancet"},{"key":"2276_CR9","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1210\/jc.2003-031014","volume":"88","author":"SJ Silverberg","year":"2003","unstructured":"S.J. Silverberg, J.P. Bilezikian, \u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease. J. Clin. Endocrinol. Metab. 88, 5348\u20135352 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2276_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0002-9343(91)90193-2","volume":"91","author":"AN Hollenberg","year":"1991","unstructured":"A.N. Hollenberg, A. Arnold, Hypercalcemia with low-normal serum intact PTH: a novel presentation of primary hyperparathyroidism. Am. J. Med. 91, 547\u2013548 (1991)","journal-title":"Am. J. Med."},{"key":"2276_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000491036","volume":"51","author":"S Corbetta","year":"2019","unstructured":"S. Corbetta, Normocalcemic hyperparathyroidism. Front. Horm. Res. 51, 23\u201339 (2019)","journal-title":"Front. Horm. Res."},{"key":"2276_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"W.D. Fraser, Hyperparathyroidism. Lancet 374, 145\u2013158 (2009)","journal-title":"Lancet"},{"key":"2276_CR13","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","volume":"365","author":"C Marcocci","year":"2011","unstructured":"C. Marcocci, F. Cetani, Clinical practice. Primary hyperparathyroidism. N. Engl. J. Med. 365, 2389\u20132397 (2011)","journal-title":"N. Engl. J. Med."},{"key":"2276_CR14","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3561\u20133569 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2276_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","volume":"34","author":"MM Tuna","year":"2016","unstructured":"M.M. Tuna, M. Caliskan, M. Unal, T. Demirci, B.A. Dogan et al. Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism. J. Bone Min. Metab. 34, 331\u2013335 (2016)","journal-title":"J. Bone Min. Metab."},{"key":"2276_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"D Shoback","year":"2008","unstructured":"D. Shoback, Clinical practice. Hypoparathyroidism. N. Engl. J. Med. 359, 391\u2013403 (2008)","journal-title":"N. Engl. J. Med."},{"key":"2276_CR17","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","volume":"101","author":"ML Brandi","year":"2016","unstructured":"M.L. Brandi, J.P. Bilezikian, D. Shoback, R. Bouillon, B.L. Clarke et al. Management of hypoparathyroidism: summary statement and guidelines. J. Clin. Endocrinol. Metab. 101, 2273\u20132283 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2276_CR18","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","volume":"173","author":"J Bollerslev","year":"2015","unstructured":"J. Bollerslev, L. Rejnmark, C. Marcocci, D.M. Shoback, A. Sitges-Serra et al. European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur. J. Endocrinol. 173, G1\u2013G20 (2015)","journal-title":"Eur. J. Endocrinol."},{"key":"2276_CR19","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"D.M. Shoback, J.P. Bilezikian, A.G. Costa, D. Dempster, H. Dralle et al. Presentation of hypoparathyroidism: etiologies and clinical features. J. Clin. Endocrinol. Metab. 101, 2300\u20132312 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2276_CR20","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ecl.2018.07.001","volume":"47","author":"NE Cusano","year":"2018","unstructured":"N.E. Cusano, J.P. Bilezikian, Signs and symptoms of hypoparathyroidism. Endocrinol. Metab. Clin. N. Am. 47, 759\u2013770 (2018)","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"2276_CR21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.beem.2018.07.001","volume":"32","author":"L Cianferotti","year":"2018","unstructured":"L. Cianferotti, G. Marcucci, M.L. Brandi, Causes and pathophysiology of hypoparathyroidism. Best Pract. Res. Clin. Endocrinol. Metab. 32, 909\u2013925 (2018)","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"2276_CR22","unstructured":"E.A. Alore, J.W. Suliburk, D.J. Ramsey, N.N. Massarweh, C.J. Balentine, et al. Diagnosis and Management of Primary Hyperparathyroidism Across theVeterans Affairs Health Care System. JAMA Intern Med. 179, 1220\u20131227 (2019)"},{"key":"2276_CR23","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-19-0316","volume":"181","author":"J Bollerslev","year":"2019","unstructured":"J. Bollerslev, C. Schalin-Jantti, L. Rejnmark, H. Siggelkow, H. Morreau et al. Management of endocrine disease: unmet therapeutic, educational and scientific needs in parathyroid disorders. Eur. J. Endocrinol. 181, P1\u2013p19 (2019)","journal-title":"Eur. J. Endocrinol."},{"key":"2276_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MED.0000000000000198","volume":"22","author":"M Pawlowska","year":"2015","unstructured":"M. Pawlowska, N.E. Cusano, An overview of normocalcemic primary hyperparathyroidism. Curr. Opin. Endocrinol. Diabetes Obes. 22, 413\u2013421 (2015)","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"2276_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.beem.2018.09.009","volume":"32","author":"NE Cusano","year":"2018","unstructured":"N.E. Cusano, C. Cipriani, J.P. Bilezikian, Management of normocalcemic primary hyperparathyroidism. Best Pract. Res. Clin. Endocrinol. Metab. 32, 837\u2013845 (2018)","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"2276_CR26","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1210\/jc.2006-2802","volume":"92","author":"H Lowe","year":"2007","unstructured":"H. Lowe, D.J. McMahon, M.R. Rubin, J.P. Bilezikian, S.J. Silverberg, Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J. Clin. Endocrinol. Metab. 92, 3001\u20133005 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2276_CR27","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/jbmr.3368","volume":"33","author":"L Underbjerg","year":"2018","unstructured":"L. Underbjerg, T. Sikjaer, L. Rejnmark, Long-term complications in patients with hypoparathyroidism evaluated by biochemical findings: a case-control study. J. Bone Min. Res. 33, 822\u2013831 (2018)","journal-title":"J. Bone Min. Res."},{"key":"2276_CR28","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1210\/jc.2016-1477","volume":"101","author":"MC Astor","year":"2016","unstructured":"M.C. Astor, K. Lovas, A. Debowska, E.F. Eriksen, J.A. Evang et al. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J. Clin. Endocrinol. Metab. 101, 3045\u20133053 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2276_CR29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bone.2018.11.012","volume":"120","author":"MR Rubin","year":"2019","unstructured":"M.R. Rubin, Skeletal manifestations of hypoparathyroidism. Bone 120, 548\u2013555 (2019)","journal-title":"Bone"},{"key":"2276_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ecl.2018.07.004","volume":"47","author":"BL Clarke","year":"2018","unstructured":"B.L. Clarke, Epidemiology and complications of hypoparathyroidism. Endocrinol. Metab. Clin. N. Am. 47, 771\u2013782 (2018)","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"2276_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1053\/j.ajkd.2008.07.036","volume":"53","author":"IH de Boer","year":"2009","unstructured":"I.H. de Boer, T.C. Rue, B. Kestenbaum, Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). Am. J. Kidney Dis. 53, 399\u2013407 (2009)","journal-title":"Am. J. Kidney Dis."},{"key":"2276_CR32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/sj.ki.5002412","volume":"72","author":"WC O\u2019Neill","year":"2007","unstructured":"W.C. O\u2019Neill, The fallacy of the calcium-phosphorus product. Kidney Int. 72, 792\u2013796 (2007)","journal-title":"Kidney Int."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02276-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-020-02276-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02276-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T23:22:52Z","timestamp":1617146572000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-020-02276-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2276"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02276-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board approved the protocol study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}